Regenstrief Institute, Inc.

04/09/2026

Treating alcohol use disorder doesn’t just improve health—it reduces costs.

Research from Regenstrief Institute and collaborators shows medications for alcohol use disorder are linked to fewer hospitalizations and lower healthcare spending across a large, real-world patient population.

https://www.regenstrief.org/article/medications-for-alcohol-use-disorder-reduce-healthcare-spending/

04/01/2026

Getting a kidney transplant shouldn’t feel like “interviewing for your life.”

The TREAT team is building the data and tools patients, providers and health systems need to better navigate the transplant process and improve access to care.

See how their work is making an impact.

https://www.regenstrief.org/projects/treat/

03/25/2026

From national media to podcasts, Regenstrief research scientist Jill Inderstrodt, PhD, MPH is shaping conversations on maternal and infant health. Featured in Yahoo News and the Infinite Women podcast, she highlights data-driven strategies to improve outcomes and strengthen care for mothers and infants.

https://www.regenstrief.org/in-the-news/infinite-women-interviews-jill-inderstrodt/
https://www.regenstrief.org/in-the-news/yahoo-news-features-dr-jill-inderstrodt/

03/19/2026

Many patients with kidney failure never make it to transplant. Not because they can’t, but because the system is too complex to navigate.

The TREAT team is working to change that. By identifying where patients are lost along the transplant journey, researchers are helping improve access to a treatment that can extend life and restore quality of life.

This , see how data is driving a more connected path to transplant.

Rachel Patzer, PhD

https://www.youtube.com/watch?v=gUfAkDUIBdc
https://www.regenstrief.org/projects/treat/

03/18/2026

Healthcare does not have a data problem. It has a coordination problem.

Research from Regenstrief and collaborators calls for treating health data like essential infrastructure to improve interoperability, trust and impact

https://www.regenstrief.org/article/reimagining-real-world-health-data-as-essential-public-infrastructure/

03/12/2026

Leadership stability and peer collaboration are key to implementing patient care programs in nursing homes, according to new research from Regenstrief Institute and IU School of Nursing.

The study evaluated the APPROACHES intervention, which trains staff to lead advance care planning conversations for residents living with dementia. Findings highlight how stable leadership and peer support help integrate these programs into everyday care.

https://www.regenstrief.org/article/leadership-stability-essential-when-implementing-care-programs/

03/10/2026

Regenstrief Institute President and CEO Rachel Patzer, PhD is in Washington, D.C., for the American Society of Nephrology’s Policy and Advocacy Hill Day, joining leaders from across the kidney health community to discuss research, care and challenges facing patients with kidney disease.

https://www.regenstrief.org/projects/treat/

03/06/2026

Access to kidney transplant isn't the same everywhere.

A study of more than 60,000 patients found that dialysis centers differ widely in how quickly patients begin transplant evaluation and reach the waitlist. Factors such as staffing, patient support and resources can play an important role.

This , new research highlights opportunities to improve transplant access.

Rachel Patzer, PhD

https://pubmed.ncbi.nlm.nih.gov/41584269/
https://www.regenstrief.org/projects/treat/

03/05/2026

Four investigators across the U.S. have received the inaugural NEXT STEPs pilot awards to advance clinical trials in nursing homes.

Led by Regenstrief Institute and IU School of Medicine, the initiative supports research to improve care delivery, symptom management and quality of life for nursing home residents.

https://www.regenstrief.org/article/nih-funds-next-steps-nursing-home-trials/

02/26/2026

As healthcare becomes more data-driven, terminology standards must keep pace with innovation.

LOINC® 2.82 delivers expanded molecular diagnostics content, new standardized social needs instruments and enhanced implementation transparency.

The release advances global health data interoperability through software enhancements and expanded terminology content.

02/16/2026

What do GLP-1 weight-loss drugs really mean for cancer risk?

Regenstrief research scientists Jiang Bian, PhD and Serena Jingchuan Guo, M.D., PhD, weigh in on emerging evidence in The Washington Post feature exploring potential benefits and unanswered questions around these widely used medications.

https://www.regenstrief.org/in-the-news/the-washington-post-interviews-drs-jiang-bian-and-serena-guo/

02/12/2026

Tarik Yuce, M.D., M.S., is advancing research on obesity treatment by studying how medical and surgical care is delivered, with a focus on access and timeliness in care. His work aims to help more patients receive effective obesity treatment when they need it.

https://www.regenstrief.org/person/tarik-yuce/